These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4920400)

  • 1. Clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma.
    Stolinsky DC; Solomon J; Pugh RP; Stevens AR; Jacobs EM; Irwin LE; Wood DA; Steinfeld JL; Bateman JR
    Cancer; 1970 Nov; 26(5):984-90. PubMed ID: 4920400
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of uracil mustard in children with Hodgkin's disease, lymphosarcoma, and soft tissue sarcoma.
    Berry DH; Sutow WW; Vietti TJ; Fernbach DJ; Sullivan MP; Haggard ME; Lane DM
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):169-73. PubMed ID: 4553449
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Schubert JC; Martin H
    Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Further observations concerning the results of treatment of Hodgkin's disease and lymphosarcoma with methylhydrazine].
    Lawkowicz W; KrzemiƄska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1970 Aug; 23(16):1419-22. PubMed ID: 5468885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 8. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

  • 9. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
    Rege VB; Owens AH
    Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase II study of KRN8602 (MX2) for malignant lymphoma].
    Okabe K; Sampi K; Kuraishi Y; Takemoto Y; Tamura K; Ogawa M
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1001-6. PubMed ID: 9644314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylhydrazine in Hodgkin's disease in reticulosarcoma].
    Finotto E; Grigoletto E; Fiorentino M
    Cancro; 1968; 21(2):165-84. PubMed ID: 4888045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and lymphographic checking of progress in lymphogranulomatosis and reticulum cell sarcoma under treatment with Natulan].
    Obrecht P; Strickstrock KH; Weissleder H
    Eur J Cancer (1965); 1966 Feb; 2(1):59-68. PubMed ID: 5336132
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of the effect of a methylhydrazine derivative in Hodgkin's disease].
    Bichel J; Jensen KB
    Folia Clin Int (Barc); 1967 Apr; 17(4):179-87. PubMed ID: 5607141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ambulatory chemotherapy of hematosarcoma].
    Finogenova IA; Abdylbaev RA
    Vopr Onkol; 1984; 30(3):77-81. PubMed ID: 6369777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
    Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
    Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
    Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
    Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 20. METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA.
    MATHE G; SCHWEISGUTH O; SCHNEIDER M; AMIEL JL; BERUMEN L; BRULE G; CATTAN A; SCHWARZENBERG L
    Lancet; 1963 Nov; 2(7317):1077-80. PubMed ID: 14063416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.